BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 17015512)

  • 41. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus--a large-scale multicentre pilot study.
    Müller-Godeffroy E; Treichel S; Wagner VM;
    Diabet Med; 2009 May; 26(5):493-501. PubMed ID: 19646189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit.
    Cemeroglu AP; Stone R; Kleis L; Racine MS; Postellon DC; Wood MA
    Pediatr Diabetes; 2010 May; 11(3):182-7. PubMed ID: 19958460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
    Shashaj B; Busetto E; Sulli N
    Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin pump therapy (continuous subcutaneous insulin infusion).
    White RD
    Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions.
    Zisser H
    Diabetes Care; 2008 Feb; 31(2):238-9. PubMed ID: 18056889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Influence of the treatment with continuous subcutaneous insulin infusion (CSII) in the improvement of the quality of life of patients with type 1 diabetes mellitus].
    Casas-Oñate ML; Montoya-Martínez D
    Enferm Clin; 2010; 20(4):216-21. PubMed ID: 20561806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled drug delivery in the treatment of diabetes mellitus.
    Irsigler K; Kritz H; Lovett RG
    Crit Rev Ther Drug Carrier Syst; 1985; 1(3):189-280. PubMed ID: 3912064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neonatal diabetes and insulin pump therapy.
    Beardsall K; Pesterfield CL; Acerini CL
    Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F223-4. PubMed ID: 21115555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin pump treatment of childhood type 1 diabetes.
    Weinzimer SA; Sikes KA; Steffen AT; Tamborlane WV
    Pediatr Clin North Am; 2005 Dec; 52(6):1677-88. PubMed ID: 16301088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin requirement in preschoolers treated with insulin pumps at the onset of type 1 diabetes mellitus.
    Szypowska A; Lipka M; Błazik M; Groele L; Pańkowska E
    Acta Paediatr; 2009 Mar; 98(3):527-30. PubMed ID: 19021593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is insulin pump therapy better than injection for adolescents with diabetes?
    Wu YP; Graves MM; Roberts MC; Mitchell AC
    Diabetes Res Clin Pract; 2010 Aug; 89(2):121-5. PubMed ID: 20488572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children.
    Schober E; Rami B
    Pediatr Diabetes; 2009 May; 10(3):198-201. PubMed ID: 19175897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetics treated with continuous subcutaneous insulin infusion pumps.
    Foley-Nolan D; Foley-Nolan A; Temperley D; Devlin J
    Ir Med J; 1989 Dec; 82(4):159-60. PubMed ID: 2516015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Continuous subcutaneous insulin infusion during general anesthesia: a case report.
    White WA; Montalvo H; Monday JM
    AANA J; 2004 Oct; 72(5):353-7. PubMed ID: 15529731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
    Hoogma RP; Schumicki D
    Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
    Bruttomesso D; Costa S; Baritussio A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.